RXRX – Recursion Pharmaceuticals-A
Investors holding2
Combined shares44,841,621
Combined reported value$185.2M
RXRX chart by TradingView. Live prices are TradingView's; all other numbers on this page are from 13F filings.
Ownership
| Investor | % of their portfolio | Change | Shares | Reported value | Period |
|---|---|---|---|---|---|
| Cathie Wood | 1.06 | Added 8.2% | 44,745,025 | $184.8M | Q3 2026 |
| Ray Dalio narrow view | 0.00 | Added 156.4% | 96,596 | $399K | Q3 2026 |
Activity: last 4 quarters
| Period | Investor | Change | Shares after | Effect on their portfolio (pts) |
|---|---|---|---|---|
| Q3 2026 | Cathie Wood | Added 8.2% | 44,745,025 | 0.08 |
| Q3 2026 | Ray Dalio narrow view | Added 156.4% | 96,596 | 0.00 |
| Q2 2026 | Cathie Wood | Added 2.8% | 41,337,632 | 0.03 |
| Q2 2026 | Ray Dalio narrow view | New | 37,667 | 0.00 |
| Q1 2026 | Cathie Wood | Added 7.8% | 40,212,769 | 0.07 |
| Q4 2025 | Cathie Wood | Added 11.2% | 37,316,856 | 0.10 |
Added: opened or increased
| Period | Investor | Change | Shares after | Effect on their portfolio (pts) |
|---|---|---|---|---|
| Q3 2026 | Cathie Wood | Added 8.2% | 44,745,025 | 0.08 |
| Q3 2026 | Ray Dalio narrow view | Added 156.4% | 96,596 | 0.00 |
| Q2 2026 | Cathie Wood | Added 2.8% | 41,337,632 | 0.03 |
| Q2 2026 | Ray Dalio narrow view | New | 37,667 | 0.00 |
| Q1 2026 | Cathie Wood | Added 7.8% | 40,212,769 | 0.07 |
| Q4 2025 | Cathie Wood | Added 11.2% | 37,316,856 | 0.10 |
Reduced: reduced or closed
No tracked investor reduced or closed this position in the last 4 quarters.
History
2 peakQ3 2026: 2 tracked investors
20212026
Shares held, last 8 quarters
| Investor | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 |
|---|---|---|---|---|---|---|---|---|
| Cathie Wood | 44.75M | 41.34M | 40.21M | 37.32M | 33.55M | 32.99M | 34.82M | 32.35M |
| Ray Dalio | 96.6K | 37.7K | – | – | – | – | – | – |
– = not held that quarter. n/a = no holdings report for that quarter (not filed yet, or reported under another manager).